Many studies have revealed that circulating long noncoding RNAs (lncRNAs) regulate gene
and protein expression in the process of hepatic fibrosis. Liver fibrosis is a reversible wound …

Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

Recent progress in our understanding of the pathways linked to progression from hepatic
insult to cirrhosis has led to numerous novel therapies being investigated as potential cures …

We prospectively investigated the changes of liver stiffness (LS) and the occurrence of
hepatocellular carcinoma (HCC) after hepatitis C virus (HCV) eradication using direct …

Background The development of direct-acting antivirals (DAA) for HCV has revolutionized
the treatment of HCV, including its treatment in patients with HIV coinfection. The aim of this …

Hepatitis C virus (HCV) cure after all-oral direct-acting antiviral (DAA) therapy greatly
improves the liver and immune system. We aimed to assess the impact of this HCV …

The hepatitis C virus (HCV) causes serious issues, affecting 71 million people globally. The
most common manifestations range from chronic hepatitis to liver cirrhosis, leading to …

Hepatitis C virus (HCV) infection is prevalent among people in prison and prisons could
therefore represent a unique opportunity to test risk groups for HCV. The aim of this sero …

Liver fibrosis is one of the major liver pathologies affecting patients worldwide. It results from
an improper tissue repair process following liver injury or inflammation. If left untreated, it …

Hepatitis C virus (HCV) infection is one of the most common causes of liver pathology. It is a
major etiological factor of continuous liver injury by triggering an uncontrolled inflammatory …